India’s dedicated journey towards tuberculosis elimination has been recognized globally, with a noteworthy 17.7 per cent decline in TB incidence from 2015 to 2023, a rate that is over twice the global average decline of 8.3 per cent, as reported by the World Health Organization in its Global Tuberculosis Report 2024.

The study was initiated at Jawaharlal Nehru Medical College at Aligarh Muslim University on September 17. A two-year follow-up of the vaccinated participants has been proposed.

Scientists have designed and synthesized novel molecules through a blend of synthetic, computational, and in-vitro studies for treating Alzheimer's Disease. These non-toxic molecules could be effective in the treatment of the disease.

In an exciting new development, researchers have created a unique way to deliver Tuberculosis medicines directly to the brain bypassing the challenging blood-brain barrier that limits the effectiveness of many brain TB medicines.

In a significant move, the Union Cabinet approved a major expansion of the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana i.e. AB PM-JAY, on September 11. Under this decision, all senior citizens aged 70 and above will receive health coverage, regardless of their income.

The Union Cabinet, chaired by Prime Minister Narendra Modi, has approved health coverage for all senior citizens aged 70 years and above irrespective of income under the flagship scheme Ayushman Bharat Pradhan Mantri Jan Arogya Yojana.